LeMaitre George W. - 11 Dec 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Reporting relationship: Chairman and CEO, Director
Issuer ticker: LMAT
Reported as of: 11 Dec 2025
Net transaction value: +$1,074,035
SEC form: 4
Accepted by SEC: 15 Dec 2025, 18:14:32 UTC
Prior SEC filing: 11 Dec 2025
Next SEC filing: 02 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Laurie A. Churchill, Attorney-in-fact

Key filing fact

LeMaitre George W. filed Form 4 for LEMAITRE VASCULAR INC (LMAT) on 15 Dec 2025.

Key facts

This page summarizes LeMaitre George W.'s Form 4 filing for LEMAITRE VASCULAR INC (LMAT).
19 reported transactions and 7 derivative rows are listed below.
Accepted by SEC: 15 Dec 2025, 18:14.

Change

Previous filing in this sequence was filed on 11 Dec 2025.
Current net transaction value: +$1,074,035.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001365737 Primary reporting owner

LeMaitre George W

Relationship: Chairman and CEO, Director
Address: C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Signature date: 15 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LMAT transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +54
Change %: +0%
Price: $0.000000
Shares after: 1,670,159
Date: 11 Dec 2025
Ownership: Direct
Footnotes: F1

LMAT transaction

Common Stock

Tax liability

Transaction value: $54,351
Shares: -652
Change %: -0.04%
Price: $83.36
Shares after: 1,669,507
Date: 11 Dec 2025
Ownership: Direct
Footnotes: F2

LMAT transaction

Common Stock

Options Exercise

Transaction value: $192,230
Shares: +5,155
Change %: +0.31%
Price: $37.29
Shares after: 1,674,662
Date: 12 Dec 2025
Ownership: Direct
Footnotes: F3

LMAT transaction

Common Stock

Options Exercise

Transaction value: $375,824
Shares: +7,733
Change %: +0.46%
Price: $48.60
Shares after: 1,682,395
Date: 12 Dec 2025
Ownership: Direct
Footnotes: F3

LMAT transaction

Common Stock

Options Exercise

Transaction value: $333,869
Shares: +7,075
Change %: +0.42%
Price: $47.19
Shares after: 1,689,470
Date: 12 Dec 2025
Ownership: Direct
Footnotes: F3

LMAT transaction

Common Stock

Options Exercise

Transaction value: $337,846
Shares: +6,182
Change %: +0.37%
Price: $54.65
Shares after: 1,695,652
Date: 12 Dec 2025
Ownership: Direct
Footnotes: F3

LMAT transaction

Common Stock

Gift

Transaction value: $0
Shares: -12,100
Change %: -0.71%
Price: $0.000000
Shares after: 1,683,552
Date: 12 Dec 2025
Ownership: Direct

LMAT transaction

Common Stock

Award

Transaction value: $0
Shares: +12,100
Change %: +57%
Price: $0.000000
Shares after: 33,400
Date: 12 Dec 2025
Ownership: LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025
Footnotes: F4

LMAT transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +39
Change %: +0%
Price: $0.000000
Shares after: 1,683,591
Date: 12 Dec 2025
Ownership: Direct
Footnotes: F1

LMAT transaction

Common Stock

Tax liability

Transaction value: $55,692
Shares: -663
Change %: -0.04%
Price: $84.00
Shares after: 1,682,928
Date: 12 Dec 2025
Ownership: Direct
Footnotes: F5

LMAT transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +39
Change %: +0%
Price: $0.000000
Shares after: 1,682,967
Date: 12 Dec 2025
Ownership: Direct
Footnotes: F1

LMAT transaction

Common Stock

Tax liability

Transaction value: $55,692
Shares: -663
Change %: -0.04%
Price: $84.00
Shares after: 1,682,304
Date: 12 Dec 2025
Ownership: Direct
Footnotes: F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LMAT transaction Derivative

Dividend Equivalent Rights

Options Exercise

Transaction value: $0
Shares: -54
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 11 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 54
Exercise price
Footnotes: F7, F8

LMAT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -5,155
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 12 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,155
Exercise price: $37.29
Footnotes: F9

LMAT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -7,733
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 12 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,733
Exercise price: $48.60
Footnotes: F9

LMAT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -7,075
Change %: -43%
Price: $0.000000
Shares after: 9,194
Date: 12 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,075
Exercise price: $47.19
Footnotes: F10

LMAT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -6,182
Change %: -30%
Price: $0.000000
Shares after: 14,191
Date: 12 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,182
Exercise price: $54.65
Footnotes: F10

LMAT transaction Derivative

Dividend Equivalent Rights

Options Exercise

Transaction value: $0
Shares: -39
Change %: -48%
Price: $0.000000
Shares after: 42
Date: 12 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 39
Exercise price
Footnotes: F11

LMAT transaction Derivative

Dividend Equivalent Rights

Options Exercise

Transaction value: $0
Shares: -39
Change %: -49%
Price: $0.000000
Shares after: 41
Date: 12 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 39
Exercise price
Footnotes: F12

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 12 footnotes

Footnote F1

Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Footnote F2

These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/11/2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

Footnote F3

Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

Footnote F4

These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.

Footnote F5

These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

Footnote F6

These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

Footnote F7

These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F8

Fractional shares released (if any) on each vesting date were settled in cash, resulting in a final balance of zero.

Footnote F9

This option is fully vested and exercisable.

Footnote F10

This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.

Footnote F11

These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F12

These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.